Recent Finacing
Recent Raise
Fulcrum Therapeutics discovers and develops small-molecule drugs that modulate gene-regulatory switches, using transcription biology, iPSC-derived cells, CRISPR screening, computational genomics and chemical libraries to target FSHD and FMR1-related diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
